In the Age of AI, Interoperability Isn’t Enough: Why Healthcare Needs Shared Understanding, Not Just Shared Data

Introduction

The healthcare sector has entered a new era defined by the growing role of artificial intelligence (AI) and advanced analytics. For years, much of the industry’s digital transformation has focused on solving the interoperability puzzle: ensuring patient data can move from one electronic health record (EHR) system to another, be exchanged between different institutions, and surface at the point of care wherever it is needed. However, as the sophistication of AI models and analytic applications deepens, many experts are warning that interoperability, while a critical foundation, is not enough on its own. The industry must also cultivate a deeper, more consistent “shared understanding” across systems—a shift that involves not just sharing data, but sharing meaning, context, and clinical nuance.

From Data Pipelines to Clinical Meaning

Interoperability’s supporters have long argued that the friction caused by data silos impedes efficiency, patient safety, care coordination, and advanced research. Over the past decade, legislative and regulatory requirements (such as the ONC’s 21st Century Cures Act, HITECH, and interoperability rules) have propelled hospitals, payers, and technology vendors toward more standardized interfaces and better data portability.

These efforts have delivered tangible benefits: clinicians can now access medication histories from outside health systems, laboratories can receive and process orders with less manual intervention, and health plans can coordinate benefits more robustly. However, these achievements have also illuminated the limitations of focusing solely on the exchange layers. Merely being able to send and receive information doesn’t guarantee the recipient system understands or can act on it without ambiguity or human intervention.

The Unique Demands of AI in Healthcare

As AI algorithms—ranging from machine learning tools for predicting complications, to natural language processing systems that extract insights from free-text notes—are woven into clinical and administrative workflows, the importance of unambiguous clinical meaning has never been more acute. AI models require structured, consistent, high-integrity data to function optimally. Variations in terminology, coding, and documentation, as well as differences in workflow and context, can introduce bias, degrade performance, and ultimately produce unreliable recommendations or insights.

The crux of the matter is “semantic interoperability,” a step beyond simple data transfer. Semantic interoperability assures that both sender and receiver not only exchange data but interpret it in the same way—a shared, trusted representation of clinical knowledge and patient context that transcends differences in platforms, vendors, and care settings.

The Challenges of Clinical Nuance

Clinical care is inherently nuanced. The meaning of a particular lab value, diagnosis code, or medication order can differ based on the patient’s medical history, clinical presentation, or care plan. For example, a recorded diagnosis of “heart failure” might mean different things in primary care, cardiology, or an intensive care unit. Among EHRs, even common terminologies such as SNOMED CT, LOINC, and ICD-10 are often used idiosyncratically, introducing uncertainty.

For AI tools to move from narrow, rules-based applications into more generalized, adaptive intelligence, they must ‘understand’ this nuance with minimal loss in translation. This requirement is fueling calls for a robust, cross-industry framework that standardizes and governs not just data syntax but also clinical semantics.

The Vision for a Shared Framework

A growing number of industry stakeholders now assert that the next leap in digital health will come not from further refining APIs or HL7 standards, but by building on top of them—a set of shared clinical vocabularies, canonical models, and collaborative governance structures. These systems must be flexible enough to evolve as biomedical knowledge grows, but robust enough to support the reproducibility and trust required by advanced analytics.

Traditional data interoperability projects have often left much of the “meaning-making” to individual organizations. But as healthcare becomes more networked—with value-based care, virtual health, and distributed research collaborations—it is evident that standardized interpretation is essential. Without it, AI risks amplifying errors or creating opaque “black box” predictions that erode trust.

Practical Implications and Industry Pushback

While the logic behind shared understanding is widely acknowledged, implementation is a formidable challenge. Health IT vendors may resist standardization if it limits proprietary advantage, and clinicians are wary of frameworks that oversimplify clinical judgment. There are also legitimate questions about who should define and maintain these standards—federal agencies, professional societies, or independent consortia?

A successful shared understanding framework needs broad stakeholder buy-in, continuous updating, and transparent governance. It must be built on real-world use cases and workflows, not just theoretical models. Examples might include the standardization of diagnostic criteria for complex diseases, governance for algorithmic updates, and transparent reporting of performance metrics across settings.

Implications for AI-Driven Care and Drug Discovery

In drug discovery and precision medicine, the limits of data exchange without shared understanding are especially acute. AI models designed to identify novel biomarkers or generate individualized treatment pathways are only as reliable as their underlying data representations. Harmonizing molecular, genomic, and phenotypic information demands rigor at both the exchange and interpretation levels.

Industry observers anticipate that organizations that successfully implement true semantic interoperability will be better positioned to leverage AI for improved outcomes, reduced costs, and greater innovation. Conversely, those that focus solely on connectivity risk falling behind as data volume, complexity, and analytic sophistication continue to accelerate.

Conclusion

The AI age has raised the stakes on interoperability. No longer is the mere movement of data across systems sufficient. A new era of healthcare demands a shared understanding—a trustworthy, standardized representation of clinical knowledge and context across platforms, organizations, and use cases. Creating this foundation will enable the full promise of AI and advanced analytics, providing a pathway to smarter, safer, and more equitable care, as well as accelerating the pace of biopharmaceutical innovation.

Source: MedCity News